Achieve life sciences reports qtrly loss per share of $1.68

Achieve reports financial results for second quarter 2020 and provides update on cytisinicline development program.achieve life sciences inc qtrly loss per share $1.68.

ACHV Ratings Summary

ACHV Quant Ranking